Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 94,851 | 98,311 | 9,384 | 12,550 | 9,792 |
| Other current assets | 64 | 34 | 50 | 67 | 252 |
| TOTAL | $96,686 | $99,784 | $10,616 | $14,459 | $11,684 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 1 | 1 | 1 | 1 |
| TOTAL | $N/A | $1 | $1 | $1 | $1 |
| Total Assets | $96,686 | $99,785 | $10,617 | $14,460 | $11,685 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,157 | 1,584 | 870 | 1,081 | 2,073 |
| Accrued Expenses | 1,536 | 978 | 592 | 536 | 1,013 |
| TOTAL | $4,693 | $2,562 | $1,741 | $2,031 | $3,587 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,693 | $2,562 | $1,741 | $2,031 | $3,587 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,970 | 3,409 | 3,409 | 1,958 | 1,958 |
| Retained earnings | -314,855 | -308,588 | -304,627 | -301,052 | -297,253 |
| TOTAL | $91,993 | $97,223 | $8,876 | $12,430 | $8,098 |
| Total Liabilities And Equity | $96,686 | $99,785 | $10,617 | $14,460 | $11,685 |